RxDoctor Payments Data

William Yap

Rheumatology · Baltimore, MDNPI 1568438802

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 66.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $4,928 and has fallen 99.5% since, to $24 in 2025.

$6,268in general payments, 2019–2025

Across 139 payments — averaging $45.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Amgen$601
  • Johnson & Johnson$233
  • Lilly USA, LLC$214
  • Novartis$185
  • Janssen Scientific Affairs, LLC$172
  • plus $721 from 11 others

What the payments were for

  • Speaking & faculty fees$3,00048%
  • Travel & lodging$571%
  • Food & beverage$3,21151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,268 in reported general payments places this provider in the 65th percentile of 173 rheumatology providers in Maryland.

See all rheumatology providers in Maryland →

Other rheumatology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →